Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

Coccidioidomycosis

SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole Safety and Pharmacokinetics of VT-1598 A Multi-center Study of Spherule-Derived Coccidioidin Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)